2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders
US7928227B2 · kind B2 · utility
9Cited by
16References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 1, 2004 |
| Grant date | Apr 19, 2011 |
| Priority date | — |
| Expiry date | Mar 1, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.